| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |